相关实验视频
Updated: Jun 26, 2026

Protocol for Long Duration Whole Body Hyperthermia in Mice
Published on: August 25, 2012
儿科患者的恶性高温症;在没有dantrolene的情况下成功管理:一个病例报告
Sangina Ranjit1, Kalpana Kharbuja1, Ashish Shrestha1
1Department of Anesthesia and Critical Care, Kathmandu University School of Medical Sciences, Dhulikhel.
恶性高温症 (MH) 是一种危险的遗传疾病,当Dantrolene无法使用时,可以通过支持性护理来管理. 早期识别和症状治疗对于患者的生存至关重要.
科学领域:
- 麻醉学 麻醉学
- 药物遗传学 药物遗传学
- 医学遗传学 医学遗传学
背景情况:
- 恶性高温症 (MH) 是一种严重的药物遗传疾病,由特定麻醉剂和生理压力引发.
- 早期诊断和及时治疗对于管理MH发作至关重要.
- 丹特罗是MH的主要药物治疗方法,但其可用性可能是一个挑战.
更多相关视频
06:43Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
相关概念视频
Increased Body Temperature
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses